MIC Capital Management (UK)’s Neumora Therapeutics NMRA Stock Holding History

MIC Capital Management (UK)’s Portfolio NMRA Stock Details NMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.58M	Hold	4,460,700	–	–	1.92%	11
2026 Q1	$8.7M	Hold	4,460,700	–	–	2.47%	9
2025 Q4	$7.98M	Hold	4,460,700	–	–	1.81%	11
2025 Q3	$8.12M	Hold	4,460,700	–	–	1.62%	11
2025 Q2	$3.27M	Hold	4,460,700	–	–	0.64%	12
2025 Q1	$4.46M	Hold	4,460,700	–	–	0.91%	13
2024 Q4	$47.3M	Hold	4,460,700	–	–	6.69%	4
2024 Q3	$58.9M	Hold	4,460,700	–	–	8.18%	3
2024 Q2	$43.8M	Hold	4,460,700	–	–	9.53%	3
2024 Q1	$61.3M	Hold	4,460,700	–	–	11.65%	3
2023 Q4	$76.1M	Hold	4,460,700	–	–	14.76%	3
2023 Q3	$62.9M	Buy	+4,460,700	New	+$55.7M	14.35%	3

Other funds holding NMRA

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

MIC Capital Management (UK)'s NMRA Position: Q2 2026 in Review

MIC Capital Management (UK) held its Neumora Therapeutics (NMRA) position steady in Q2 2026 at 4,460,700 shares worth $7.58M. The position accounts for 1.92% of the portfolio, ranked #11.

MIC Capital Management (UK) first reported a position in NMRA in Q3 2023 and has held it in 12 quarters since. The position peaked at $76.1M in Q4 2023. 113 funds tracked by Wall St. Rank hold NMRA as of Q2 2026.

MIC Capital Management (UK) held 4,460,700 shares of Neumora Therapeutics worth $7.58M as of Q2 2026.
MIC Capital Management (UK) left its Neumora Therapeutics share count unchanged in Q2 2026.
Neumora Therapeutics made up 1.92% of MIC Capital Management (UK)'s portfolio in Q2 2026, its #11 holding.
MIC Capital Management (UK) first reported a position in Neumora Therapeutics in Q3 2023 and has held it in 12 quarters since.
MIC Capital Management (UK)'s Neumora Therapeutics position peaked at $76.1M in Q4 2023.
113 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2026.

Based on MIC Capital Management (UK)'s 13F filing for Q2 2026, filed 10 Aug 2026.